Emerging Therapeutic Segments in the European Biopharmaceutical Markets

Table of Contents

1. EXECUTIVE SUMMARY

• Introduction
  • 1. Summary

2. MARKET OVERVIEW

3. MARKET ANALYSIS

• Market Introduction
  • 1. Introduction
  • 2. Measurements
  • 3. Main Classes of Biopharmaceuticals
  • 4. Recent Product Approvals in Europe
  • 5. Competitive Structure
• Research Scope and Methodology
  • 1. Scope and Segmentation
  • 2. Research Methodology
• Market Trends
  • 1. Industry Challenges
  • 2. Market Drivers
  • 3. Market Restraints
• Pipeline Analysis
  • 1. Antisense Therapies
  • 2. Gene Therapies
  • 3. Cell Therapies

4. REVENUE ANALYSIS

• Total Market Forecasts
  • 1. Revenue Forecasts
• Segment Analysis
  • 1. Segment Forecasts
  • 2. Antisense Therapies
  • 3. Gene Therapies
  • 4. Cell Therapies

5. DECISION SUPPORT DATABASES

• Databases
  • 1. Cancer Cases
  • 2. Prevalence of Arthritis
  • 3. Prevalence of Multiple Sclerosis
  • 4. Prevalence of Cardiovascular Diseases
  • 5. Pharma Government Biotech R&D Investment